Profile picture of Paul Conway

Dr Paul Conway

Profile picture of Paul Conway

BHlthSci, GradDipHlthSci, MBBS (Hons), FRANZCR

Radiation Oncologist
Call
Enquire
Referrals

Dr Paul Conway provides compassionate, patient-centred cancer care. He combines advanced techniques and technology to offer the highest quality of treatment available—a level of care he would trust for his own family.

Biography

Dr Paul Conway is a Radiation Oncologist at Icon Cancer Centre in Richmond, Freemasons, Moreland, Mulgrave, Holmesglen, and Mildura. He completed his Bachelor of Medicine, Bachelor of Surgery (MBBS) with First Class Honours at the University of Queensland in 2013. He undertook specialty training at the Royal Brisbane and Women’s Hospital, Alfred Health, and Peter MacCallum Cancer Centre, becoming a Fellow of the Royal Australian and New Zealand College of Radiologists (FRANZCR) in 2021.

His commitment to advanced cancer treatments took him to Japan, where he gained valuable insights into Proton Beam Therapy at the National Cancer Centre Hospital East and Tsukuba Proton Beam Therapy Centre. Additionally, he has completed training and credentialing in the CyberKnife system, the most advanced stereotactic radiation delivery system available. He further refined his skills during a two-year fellowship under Dr Pat Bowden, focusing on advanced techniques in managing urologic and metastatic diseases, including over 250 supervised courses of stereotactic radiotherapy for oligometastatic disease. Dr Conway now collaborates with Dr Pat Bowden, leveraging their combined expertise to benefit patients.

Dr Conway’s current research interests centre on advancements in imaging and treatment technologies. His research includes dynamic PET imaging and novel tracer technology to improve disease detection and characterisation for precise treatment planning. He is actively involved in the follow-up of the TRANSFORM trial, led by Dr Pat Bowden, which is the largest study of its kind investigating the use of stereotactic radiotherapy for treating oligometastatic prostate cancer.

In clinical practice, Dr Conway serves as the Radiation Oncology representative on the medical advisory committee for John Fawkner Hospital in Victoria, where he helps shape best practices and ensures excellence in patient care. He specialises in treating a diverse range of solid tumour malignancies, with expertise in urological cancers (including prostate cancer), gastrointestinal cancers, breast cancer, lung and central nervous system (CNS) cancers, and oligometastatic disease. His holistic approach and dedication to personalised medicine ensure each patient receives comprehensive, compassionate care tailored to their unique needs.

Publications

  • Detection of PSMA avid disease on extended axial field-of-view PET/CT. S Thomas, J Callahan, P Conway, D Moon, H Morgan, J Ingbritsen, M Munro, RE Ware, P Dundee, RJ Hicks. [Conference presentation]. APCC 2024.

  • Five-year outcomes of fractionated stereotactic body radiotherapy for oligometastatic prostate cancer from the TRANSFORM phase II trial. A See, P Conway, M Frydenberg, H Haxhimolla, A Costello, D Moon, P Ruljancich, J Grummet, G Pranavan, J Peters, L Smyth, SM Gwini, DP McKenzie, P Bowden.  International Journal of Cancer. Jun 2024.

  • Oesophageal cancer treatment patterns, timeliness of care and outcomes in the Loddo Mallee region of Victoria: a retrospective cohort study. P. Conway, M. Leach, N. Tejani, A. Robinson, Y. Shethia & I. Solo. Journal of Medical Imaging and Radiation Oncology. Feb 2021.

  • Radiation necrosis and therapeutic outcomes in patients treated with linear accelerator-based hypofractionated stereotactic radiosurgery for intact brain metastases. Q Zhang, Daniel Hamilton, P Conway, SJ Xie, N Haghighi, A Lasocki. Journal of Medical Imaging and Radiation Oncology. Apr 2023.

Special Interests

Dr Paul Conway accepts referrals for all cancer types, with a special clinical interest in:

  • Brain and spine (CNS) cancer
  • Breast cancer
  • Gastrointestinal cancer
  • Oligometastatic disease
  • Prostate cancer

Languages spoken

  • English

Visiting Locations

  • Northpark Private Hospital

Affiliations & Memberships

  • Australia and New Zealand UpToDate User Group
  • Royal Australian and New Zealand College of Radiologists (RANZCR)
  • Trans Tasman Radiation Oncology Group (TROG)

Publications

  • Detection of PSMA avid disease on extended axial field-of-view PET/CT. S Thomas, J Callahan, P Conway, D Moon, H Morgan, J Ingbritsen, M Munro, RE Ware, P Dundee, RJ Hicks. [Conference presentation]. APCC 2024.

  • Five-year outcomes of fractionated stereotactic body radiotherapy for oligometastatic prostate cancer from the TRANSFORM phase II trial. A See, P Conway, M Frydenberg, H Haxhimolla, A Costello, D Moon, P Ruljancich, J Grummet, G Pranavan, J Peters, L Smyth, SM Gwini, DP McKenzie, P Bowden.  International Journal of Cancer. Jun 2024.

  • Oesophageal cancer treatment patterns, timeliness of care and outcomes in the Loddo Mallee region of Victoria: a retrospective cohort study. P. Conway, M. Leach, N. Tejani, A. Robinson, Y. Shethia & I. Solo. Journal of Medical Imaging and Radiation Oncology. Feb 2021.

  • Radiation necrosis and therapeutic outcomes in patients treated with linear accelerator-based hypofractionated stereotactic radiosurgery for intact brain metastases. Q Zhang, Daniel Hamilton, P Conway, SJ Xie, N Haghighi, A Lasocki. Journal of Medical Imaging and Radiation Oncology. Apr 2023.

Search

Contact us
Become a patient